Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 4 studies | 26% ± 11% | |
glutamatergic neuron | 4 studies | 28% ± 16% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 13% | |
interneuron | 4 studies | 34% ± 26% | |
astrocyte | 3 studies | 26% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 35% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ureter | 0% | 0 | 0 / 0 | 100% | 6.01 | 1 / 1 |
brain | 0% | 0 | 0 / 0 | 100% | 35.51 | 703 / 705 |
eye | 0% | 0 | 0 / 0 | 98% | 8.87 | 78 / 80 |
adrenal gland | 0% | 0 | 0 / 0 | 96% | 13.62 | 220 / 230 |
tonsil | 0% | 0 | 0 / 0 | 96% | 9.35 | 43 / 45 |
prostate | 0% | 0 | 0 / 0 | 95% | 7.02 | 479 / 502 |
pancreas | 0% | 0 | 0 / 0 | 94% | 9.73 | 168 / 178 |
ovary | 0% | 0 | 0 / 0 | 94% | 12.30 | 404 / 430 |
thymus | 0% | 0 | 0 / 0 | 94% | 9.74 | 566 / 605 |
esophagus | 0% | 0 | 0 / 0 | 91% | 10.53 | 167 / 183 |
lung | 0% | 0 | 0 / 0 | 87% | 7.95 | 1005 / 1155 |
skin | 0% | 0 | 0 / 0 | 87% | 7.55 | 410 / 472 |
kidney | 0% | 0 | 0 / 0 | 86% | 7.88 | 772 / 901 |
breast | 0% | 0 | 0 / 0 | 85% | 6.03 | 955 / 1118 |
uterus | 0% | 0 | 0 / 0 | 85% | 9.67 | 390 / 459 |
stomach | 0% | 0 | 0 / 0 | 81% | 6.39 | 231 / 286 |
bladder | 0% | 0 | 0 / 0 | 78% | 5.73 | 393 / 504 |
intestine | 0% | 0 | 0 / 0 | 75% | 5.07 | 397 / 527 |
liver | 0% | 0 | 0 / 0 | 61% | 4.81 | 248 / 406 |
lymph node | 0% | 0 | 0 / 0 | 45% | 2.61 | 13 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_1903577 | Biological process | cellular response to L-arginine |
GO_0005829 | Cellular component | cytosol |
GO_0061700 | Cellular component | GATOR2 complex |
GO_0034618 | Molecular function | arginine binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CASTOR2 |
Protein name | Cytosolic arginine sensor for mTORC1 subunit 2 (Cellular arginine sensor for mTORC1 protein 2) (GATS-like protein 2) |
Synonyms | GATSL1 GATSL2 |
Description | FUNCTION: Functions as a negative regulator of the TORC1 signaling pathway through the GATOR complex. As part of homodimers or heterodimers with CASTOR1, directly binds and inhibits the GATOR subcomplex GATOR2 and thereby mTORC1. Does not directly bind arginine, but binding of arginine to CASTOR1 disrupts the interaction of CASTOR2-containing heterodimers with GATOR2 which can in turn activate mTORC1 and the TORC1 signaling pathway. . |
Accessions | A6NHX0 ENST00000616305.2 |